View all news

ROCS has reached its target!

6 September 2018

ROCS has reached its target!

The ROCS (Radiotherapy after Oesophageal Cancer Stenting) study (https://clinicaltrials.gov/ct2/show/NCT01915693) has reached the 220 patients final accrual.  Recruitment has now ended and follow up will continue until the end of November.

The Bristol team recruited 27 patients and were the second highest recruiter to the study.

Well done to everyone involved.

Edit this page